Research Library

By providing regulated and safe access to medical cannabis to people with demonstrated need, the Texas Legislature can provide justified relief, help reduce the opioid epidemic, and save Texas millions of dollars, write the authors.

The recent rise in opioid-related overdose deaths is part of a larger trend in drug use that started over 40 years ago, writes Katharine Neill Harris, the Alfred C. Glassell, III, Fellow in Drug Policy.

This working paper examines the lack of reliable data on the number and quality of drug treatment services in Harris County.

The Commission on Combatting Drug Addiction and the Opioid Crisis appointed by President Trump released its report on Monday, July 31. Drug policy fellow Katharine Neill Harris assesses the commission's recommendations in the Baker Institute Blog.

Drug Policy Program director Bill Martin summarizes the scientific and fiscal evidence supporting the efficacy of syringe exchange programs and outlines a framework for public policies to deal with this aspect of drug use and abuse.

The U.S. prosecution of drug kingpin El Chapo Guzman could open a Pandora’s box that exposes corrupt officials in both countries, writes fellow Gary Hale in the Baker Institute Blog.

Using charts, figures and graphs of this survey data originally created by former career intelligence analyst Brian C. Bennett and updated by the Drug Policy Program, this issue brief offers an overview of drug use trends in America over the last four decades. The brief is part of a larger online project chronicling the pattern of the use and abuse of individual drugs over (in most cases) more than 40 years.

This issue brief examines how globalization has aided the spread of transnational organized crime and the challenges to combating it.

Katharine Neill, the Alfred C. Glassell, III Postdoctoral Fellow in Drug Policy, explains what you should know about the Justice Department's plan to release 6,000 nonviolent drug offenders from federal prison during four days in October and November.